SLC6A3 and Parkinson disease: Considering the link between DAT and Parkinson’s disease, it is tempting to suggest that this might be responsible, at least in part, for the PD-like symptoms of acrylamide neurotoxicity (McHugh and Buckley, 2015; Jayaramayya et al., 2020).